FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mei-Ping Kung

Research Profile

Anatomy

Brain

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Living Beings

Procedures

Disorders

Co-author Network

Publications

TOP 3
Ing-Tsung Hsiao; Chia-Ju Hsieh; Chin-Chang Huang; Mei-Ping Kung; Shiaw-Pyng Wey; Tzu-Chen Yen; Kun-Ju Lin
Perfusion-like template and standardized normalization-based brain image analysis using (18)F-florbetapir (AV-45/Amyvid) PET.
Kuo-Lun Huang; Mei-Ping Kung; Hung-Chou Kuo; Kun-Ju Lin; Yau-Yau Wai; Shiaw-Pyng Wey; Tzu-Chen Yen; Wen-Li Chuang; Ing-Tsung Hsiao; Chia-Ju Hsieh; Wen-Chuin Hsu; Chin-Chang Huang
Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
Ko-Ting Chao; Ing-Tsung Hsiao; Chia-Ju Hsieh; Mei-Ping Kung; Hsin-Hsin Tsao; Yi-Hsin Weng; Shiaw-Pyng Wey; Tzu-Chen Yen; Kun-Ju Lin
Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mei-Ping Kung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ing-Tsung Hsiao; Chia-Ju Hsieh; Chin-Chang Huang; Mei-Ping Kung; Shiaw-Pyng Wey; Tzu-Chen Yen; Kun-Ju Lin
Perfusion-like template and standardized normalization-based brain image analysis using (18)F-florbetapir (AV-45/Amyvid) PET.
European journal of nuclear medicine and molecular imaging 2013;40(6):908-20.
2013: Kuo-Lun Huang; Mei-Ping Kung; Hung-Chou Kuo; Kun-Ju Lin; Yau-Yau Wai; Shiaw-Pyng Wey; Tzu-Chen Yen; Wen-Li Chuang; Ing-Tsung Hsiao; Chia-Ju Hsieh; Wen-Chuin Hsu; Chin-Chang Huang
Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
PloS one 2013;8(3):e58974.
2012: Ko-Ting Chao; Ing-Tsung Hsiao; Chia-Ju Hsieh; Mei-Ping Kung; Hsin-Hsin Tsao; Yi-Hsin Weng; Shiaw-Pyng Wey; Tzu-Chen Yen; Kun-Ju Lin
Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
Synapse (New York, N.Y.) 2012;66(9):823-31.
2012: Mei-Ping Kung; Kun-Ju Lin; Chi-Chang Weng; Ing-Tsung Hsiao; Tzu-Chen Yen; Shiaw-Pyng Wey
Amyloid plaque imaging from IMPY/SPECT to AV-45/PET.
Chang Gung medical journal 2012;35(3):211-8.
2009: Wenchao Qu; Karl Ploessl; Hong Truong; Mei-Ping Kung; Hank F Kung
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
Bioorganic & medicinal chemistry letters 2009;19(13):3382-5.
2008: Hank F Kung; Brian P Lieberman; Zhi-Ping Zhuang; Shunichi Oya; Mei-Ping Kung; Seok-Rye Choi; Karl Poessl; Eric Blankemeyer; Catherine Hou; Daniel M Skovronsky; Michael R Kilbourn
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
Nuclear medicine and biology 2008;35(8):825-37.
2008: Wenchao Qu; Seok-Rye Choi; Catherine Hou; Zhiping Zhuang; Shunichi Oya; Wei Zhang; Mei-Ping Kung; Rajesh Manchandra; Daniel M Skovronsky; Hank F Kung
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.
Bioorganic & medicinal chemistry letters 2008;18(17):4823-7.
2008: Mei-Ping Kung; Catherine Hou; Brian P Lieberman; Shunichi Oya; Datta E Ponde; Eric Blankemeyer; Daniel M Skovronsky; Michael R Kilbourn; Hank F Kung
In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(7):1171-6.
2008: Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Mei-Ping Kung; Hank F Kung
2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.
Nuclear medicine and biology 2008;35(4):447-58.
2008: Karl Plössl; Rajesh Chandra; Wenchao Qu; Brian P Lieberman; Mei-Ping Kung; Rong Zhou; Bin Huang; Hank F Kung
A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent.
Nuclear medicine and biology 2008;35(1):83-90.
2008: Balagopal Lakshmi; Mei-Ping Kung; Brian Lieberman; Jun Zhao; Rikki Waterhouse; Hank F Kung
(R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.
Nuclear medicine and biology 2008;35(1):43-52.
2008: Izumi Maezawa; Hyun-Seok Hong; Ruiwu Liu; Chun-Yi Wu; R Holland Cheng; Mei-Ping Kung; Hank F Kung; Kit S Lam; Salvatore Oddo; Frank M LaFerla; Lee-Way Jin
Congo red and thioflavin-T analogs detect Abeta oligomers.
Journal of neurochemistry 2008;104(2):457-68.
2007: Ajit K Parhi; Julie L Wang; Shunichi Oya; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.
Journal of medicinal chemistry 2007;50(26):6673-84.
2007: Hank F Kung; Mei-Ping Kung; Shiaw-Pyng Wey; Kun-Ju Lin; Tzu-Chen Yen
Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
Nuclear medicine and biology 2007;34(7):787-9.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Shunichi Oya; Hank F Kung
Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.
Journal of medicinal chemistry 2007;50(14):3380-7.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Lee-Way Jin; Hank F Kung
Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection.
Bioorganic & medicinal chemistry letters 2007;17(13):3581-4.
2007: Rajesh Chandra; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Lee-Way Jin; Hank F Kung
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(10):2415-23.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Tyler E Benedum; Hank F Kung
Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(9):2157-65.
2007: Mei-Ping Kung; Catherine Hou; Rajesh Goswami; Datta E Ponde; Michael R Kilbourn; Hank F Kung
Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
Nuclear medicine and biology 2007;34(3):239-46.
2007: Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Catherine Hou; Rajesh Goswami; Datta E Ponde; Mei-Ping Kung; Hank F Kung
Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
Nuclear medicine and biology 2007;34(3):233-7.
2007: Shunichi Oya; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
5-Chloro-2-(2'-((dimethylamino)methyl)-4'-iodophenylthio)benzenamine: a new serotonin transporter ligand.
Nuclear medicine and biology 2007;34(2):129-39.
2007: Karin A Stephenson; Rajesh Chandra; Zhi-Ping Zhuang; Catherine Hou; Shunichi Oya; Mei-Ping Kung; Hank F Kung
Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.
Bioconjugate chemistry 2007;18(1):238-46.
2007: Wei Zhang; Mei-Ping Kung; Shunichi Oya; Catherine Hou; Hank F Kung
18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Nuclear medicine and biology 2007;34(1):89-97.
2006: Rajesh Goswami; Datta E Ponde; Mei-Ping Kung; Catherine Hou; Michael R Kilbourn; Hank F Kung
Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
Nuclear medicine and biology 2006;33(6):685-94.
2006: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis of biphenyltrienes as probes for beta-amyloid plaques.
Journal of medicinal chemistry 2006;49(9):2841-4.
2006: Andrew B Newberg; Nancy Wintering; Karl Plössl; John Hochold; Michael G Stabin; Marianne Watson; Daniel M Skovronsky; Christopher M Clark; Mei-Ping Kung; Hank F Kung
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):748-54.
2006: Rajesh Chandra; Mei-Ping Kung; Hank F Kung
Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
Bioorganic & medicinal chemistry letters 2006;16(5):1350-2.
2006: Catherine Hou; Zhude Tu; Robert Mach; Hank F Kung; Mei-Ping Kung
Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Nuclear medicine and biology 2006;33(2):203-9.
2005: Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna Maier; Hank F Kung
F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Nuclear medicine and biology 2005;32(8):799-809.
2005: Mei-Ping Kung; Hank F Kung
Mass effect of injected dose in small rodent imaging by SPECT and PET.
Nuclear medicine and biology 2005;32(7):673-8.
2005: Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna Maier; Hank F Kung
F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2005;48(19):5980-8.
2005: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Ploessl; Hank F Kung
Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Nuclear medicine and biology 2005;32(2):171-84.
2004: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Daniel M Skovronsky; Hank F Kung
Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Brain research 2004;1025(1-2):98-105.
2004: Hank F Kung; Suzanne Newman; Seok-Rye Choi; Shunichi Oya; Catherine Hou; Zhi-Ping Zhuang; Paul D Acton; Karl Plössl; Jeffrey Winkler; Mei-Ping Kung
2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.
Journal of medicinal chemistry 2004;47(21):5258-64.
2004: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Alan J Cross; Donna Maier; Hank F Kung
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
European journal of nuclear medicine and molecular imaging 2004;31(8):1136-45.
2004: Mei-Ping Kung; Seok-Rye Choi; Catherine Hou; Zhi-Ping Zhuang; Catherine Foulon; Hank F Kung
Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
Nuclear medicine and biology 2004;31(5):533-41.
2004: Mei-Ping Kung; Zhi-Ping Zhuang; Catherine Hou; Hank F Kung
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.
Journal of molecular neuroscience : MN 2004;24(1):49-53.
2003: Hang F Kung; Mei-Ping Kung; Zhi-Ping Zhuang; Catherine Hou; Chi-Wan Lee; Karl Plössl; Bing Zhuang; Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Iodinated tracers for imaging amyloid plaques in the brain.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(6):418-26.
2003: Adam S Crystal; Benoit I Giasson; Alexander Crowe; Mei-Ping Kung; Zhi-Ping Zhuang; John Q Trojanowski; Virginia M-Y Lee
A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.
Journal of neurochemistry 2003;86(6):1359-68.
2003: Chi-Wan Lee; Mei-Ping Kung; Catherine Hou; Hank F Kung
Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain.
Nuclear medicine and biology 2003;30(6):573-80.
2003: Masahiro Ono; Alan Wilson; Jose Nobrega; David Westaway; Paul Verhoeff; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2003;30(6):565-71.
2003: Mei-Ping Kung; Daniel M Skovronsky; Catherine Hou; Zhi-Ping Zhuang; Tamar L Gur; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Journal of molecular neuroscience : MN 2003;20(1):15-24.
2003: Zhi-Ping Zhuang; Mei-Ping Kung; Alan Wilson; Chi-Wan Lee; Karl Plössl; Catherine Hou; David M Holtzman; Hank F Kung
Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2003;46(2):237-43.
2003: Mei-Ping Kung; Zhi-Ping Zhuang; Catherine Hou; Lee-Way Jin; Hank F Kung
Characterization of radioiodinated ligand binding to amyloid beta plaques.
Journal of molecular neuroscience : MN 2003;20(3):249-54.
2003: Hank F Kung; Mei-Ping Kung; Seok-Rye Choi
Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
Seminars in nuclear medicine 2003;33(1):2-13.
2002: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Bin Zhang; Daniel M Skovronsky; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Brain research 2002;956(2):202-10.
2002: Paul D Acton; Catherine Hou; Mei-Ping Kung; Karl Plössl; Cindy L Keeney; Hank F Kung
Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
European journal of nuclear medicine and molecular imaging 2002;29(11):1507-15.
2002: Masahiro Ono; Mei-Ping Kung; Catherine Hou; Hank F Kung
Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2002;29(6):633-42.
2002: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Daniel M Skovronsky; Bin Zhang; Tamar L Gur; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
Journal of molecular neuroscience : MN 2002;19(1-2):7-10.
2002: Paul D Acton; Mei-Ping Kung; Catherine Hou; Karl Plössl; Cindy Keeney; Hank F Kung
Ultra-high resolution single photon emission tomography imaging of the mouse striatum.
European journal of nuclear medicine and molecular imaging 2002;29(3):446.
2001: Hank F Kung; Chi-Wan Lee; Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Plössl
Novel stilbenes as probes for amyloid plaques.
Journal of the American Chemical Society 2001;123(50):12740-1.
2001: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Plössl; Daniel M Skovronsky; Tamar L Gur; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain.
Nuclear medicine and biology 2001;28(8):887-94.
2001: M Luise Schmidt; Teresa Schuck; S Sheridan; Mei-Ping Kung; H Kung; Zhi-Ping Zhuang; Catherine Bergeron; J S Lamarche; Daniel M Skovronsky; Benoit I Giasson; Virginia M-Y Lee; John Q Trojanowski
The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.
The American journal of pathology 2001;159(3):937-43.
2001: Chi-Wan Lee; Zhi-Ping Zhuang; Mei-Ping Kung; Karl Plössl; Daniel M Skovronsky; Tamar L Gur; Catherine Hou; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
Journal of medicinal chemistry 2001;44(14):2270-5.
2001: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Daniel M Skovronsky; Tamar L Gur; Karl Plössl; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
Journal of medicinal chemistry 2001;44(12):1905-14.
2000: Seok-Rye Choi; Catherine Hou; Shunichi Oya; M Mu; Mei-Ping Kung; M Siciliano; Paul D Acton; Hank F Kung
Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
Synapse (New York, N.Y.) 2000;38(4):403-12.
2000: Gregg D Stanwood; R P Artymyshyn; Mei-Ping Kung; Hank F Kung; Irwin Lucki; P McGonigle
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1223-31.
2000: Daniel M Skovronsky; Bin Zhang; Mei-Ping Kung; Hank F Kung; John Q Trojanowski; Virginia M-Y Lee
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7609-14.
2000: Shunichi Oya; Seok-Rye Choi; Catherine Hou; M Mu; Mei-Ping Kung; Paul D Acton; M Siciliano; Hank F Kung
2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
Nuclear medicine and biology 2000;27(3):249-54.
1999: Y Xu; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs.
Nuclear medicine and biology 1999;26(7):833-9.
1999: M Mu; Mei-Ping Kung; Karl Plössl; Paul D Acton; P David Mozley; Hank F Kung
A simplified method to determine [99mTc]TRODAT-1 in human plasma.
Nuclear medicine and biology 1999;26(7):821-5.
1999: Paul D Acton; Mei-Ping Kung; M Mu; Karl Plössl; Catherine Hou; M Siciliano; Shunichi Oya; Hank F Kung
Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
European journal of nuclear medicine 1999;26(8):854-61.
1999: Mei-Ping Kung; Catherine Hou; Shunichi Oya; M Mu; Paul D Acton; Hank F Kung
Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
European journal of nuclear medicine 1999;26(8):844-53.
1999: Seok-Rye Choi; Mei-Ping Kung; Karl Plössl; SK Meegalla; Hank F Kung
An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1.
Nuclear medicine and biology 1999;26(4):461-6.
1999: Paul D Acton; SA Kushner; Mei-Ping Kung; P David Mozley; Karl Plössl; Hank F Kung
Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
European journal of nuclear medicine 1999;26(5):518-26.
1999: SH Dresel; Mei-Ping Kung; X F Huang; Karl Plössl; Catherine Hou; SK Meegalla; G Patselas; M Mu; Janet R Saffer; Hank F Kung
Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):660-6.
1999: SH Dresel; Mei-Ping Kung; X Huang; Karl Plössl; Catherine Hou; Chyng-Yann Shiue; Jonathan Karp; Hank F Kung
In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
European journal of nuclear medicine 1999;26(4):342-7.
1999: Zhi-Ping Zhuang; Mei-Ping Kung; M Mu; Catherine Hou; Hank F Kung
99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Bioconjugate chemistry 1999;10(2):159-68.
1999: Shunichi Oya; Mei-Ping Kung; Paul D Acton; M Mu; Catherine Hou; Hank F Kung
A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.
Journal of medicinal chemistry 1999;42(3):333-5.
1999: Zhi-Ping Zhuang; Karl Plössl; Mei-Ping Kung; M Mu; Hank F Kung
Neutral and stereospecific Tc-99m complexes: [99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT).
Nuclear medicine and biology 1999;26(2):217-24.
1999: SA Kushner; WT McElgin; Mei-Ping Kung; P David Mozley; Karl Plössl; SK Meegalla; M Mu; SH Dresel; JM Vessotskie; N Lexow; Hank F Kung
Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):150-8.
1998: SK Meegalla; Karl Plössl; Mei-Ping Kung; DA Stevenson; M Mu; SA Kushner; L M Liable-Sands; A L Rheingold; Hank F Kung
Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Journal of medicinal chemistry 1998;41(4):428-36.
1998: Shunichi Oya; Karl Plössl; Mei-Ping Kung; DA Stevenson; Hank F Kung
Small and neutral Tc(v)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents.
Nuclear medicine and biology 1998;25(2):135-40.
1998: Zhi-Ping Zhuang; Mei-Ping Kung; M Mu; Hank F Kung
Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Journal of medicinal chemistry 1998;41(2):157-66.
1998: SH Dresel; Mei-Ping Kung; Karl Plössl; SK Meegalla; Hank F Kung
Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
European journal of nuclear medicine 1998;25(1):31-9.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Brain research 1997;778(1):89-98.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Neuropharmacology 1997;36(7):999-1007.
1997: A R Allen; A Singh; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung; Irwin Lucki
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1997;57(1-2):301-7.
1997: Mei-Ping Kung; DA Stevenson; Karl Plössl; SK Meegalla; A Beckwith; W D Essman; M Mu; I Lucki; Hank F Kung
[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
European journal of nuclear medicine 1997;24(4):372-80.
1997: Chyng-Yann Shiue; Grace G Shiue; P David Mozley; Mei-Ping Kung; Zhi-Ping Zhuang; H J Kim; Hank F Kung
P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
Synapse (New York, N.Y.) 1997;25(2):147-54.
1997: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; SA Kushner; WT McElgin; P David Mozley; Hank F Kung
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Journal of medicinal chemistry 1997;40(1):9-17.
1997: Mei-Ping Kung; DA Stevenson; Zhi-Ping Zhuang; JM Vessotskie; S Chumpradit; X M Sun; Hank F Kung
Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Life sciences 1997;60(2):91-100.
1996: Robert H Mach; Michael A Nader; Richard L Ehrenkaufer; SW Line; CR Smith; R R Luedtke; Mei-Ping Kung; Hank F Kung; David Lyons; Thomas E Morton
Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
Synapse (New York, N.Y.) 1996;24(4):322-33.
1996: P David Mozley; H J Kim; Ruben C Gur; Klaus Tatsch; L R Muenz; W T McElgin; Mei-Ping Kung; M Mu; A M Myers; Hank F Kung
Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1965-70.
1996: Hank F Kung; D Frederick; H J Kim; W McElgin; Mei-Ping Kung; M Mu; P David Mozley; JM Vessotskie; DA Stevenson; SA Kushner; Zhi-Ping Zhuang
In vivo SPECT imaging of 5-HT1A receptors with [123I]p-MPPI in nonhuman primates.
Synapse (New York, N.Y.) 1996;24(3):273-81.
1996: Hank F Kung; H J Kim; Mei-Ping Kung; SK Meegalla; Karl Plössl; H K Lee
Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
European journal of nuclear medicine 1996;23(11):1527-30.
1996: Hank F Kung; DA Stevenson; Zhi-Ping Zhuang; Mei-Ping Kung; D Frederick; S D Hurt
New 5-HT1A receptor antagonist: [3H]p-MPPF.
Synapse (New York, N.Y.) 1996;23(4):344-6.
1996: Shunichi Oya; Mei-Ping Kung; D Frederick; Hank F Kung
Novel TcVO(III) N2S2 complexes: interconversion by redox reaction.
Nuclear medicine and biology 1996;23(5):589-93.
1996: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; D Frederick; Hank F Kung
Tc-99m-labeled tropanes as dopamine transporter imaging agents.
Bioconjugate chemistry 1996;7(4):421-9.
1996: Mei-Ping Kung; M Mu; Zhi-Ping Zhuang; Hank F Kung
NCS-MPP (4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-isothiocyanobenz amido]-ethyl-piperazine): a high affinity and irreversible 5-HT1A receptor ligand.
Life sciences 1996;58(3):177-86.
1996: P David Mozley; J B Stubbs; H J Kim; W McElgin; Mei-Ping Kung; SK Meegalla; Hank F Kung
Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):151-9.
1995: Robert T Malison; JM Vessotskie; Mei-Ping Kung; W McElgin; G Romaniello; H J Kim; Mark M Goodman; Hank F Kung
Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2290-7.
1995: Shunichi Oya; Mei-Ping Kung; D Frederick; Hank F Kung
New bisaminoethanethiol (BAT) ligands which form two interconvertible Tc-99m complexes.
Nuclear medicine and biology 1995;22(6):749-57.
1995: Mei-Ping Kung; W D Essman; D Frederick; SK Meegalla; Mark M Goodman; M Mu; Irwin Lucki; Hank F Kung
IPT: a novel iodinated ligand for the CNS dopamine transporter.
Synapse (New York, N.Y.) 1995;20(4):316-24.
1995: P David Mozley; J B Stubbs; H J Kim; W McElgin; S Chumpradit; Mei-Ping Kung; G Romaniello; Hank F Kung
Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1322-31.
1995: JM Vessotskie; Mei-Ping Kung; S Chumpradit; G Romaniello; W McElgin; D Frederick; Robert T Malison; Hank F Kung
In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1282-8.
1995: K D Burris; M A Pacheco; T M Filtz; Mei-Ping Kung; Hank F Kung; P B Molinoff
Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(4):335-45.
1995: D J Canney; Mei-Ping Kung; Hank F Kung
Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
Nuclear medicine and biology 1995;22(4):527-35.
1995: Mei-Ping Kung; D Frederick; M Mu; Zhi-Ping Zhuang; Hank F Kung
4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
The Journal of pharmacology and experimental therapeutics 1995;272(1):429-37.
1995: Zhi-Ping Zhuang; Mei-Ping Kung; W Clarke; S Maayani; M Mu; Hank F Kung
Synthesis of (+)-(R)- and (-)-(S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)] aminotetralin: new 5-HT1A receptor ligands.
Chirality 1995;7(6):452-8.
1994: Zhi-Ping Zhuang; Mei-Ping Kung; S Chumpradit; M Mu; Hank F Kung
Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands.
Journal of medicinal chemistry 1994;37(26):4572-5.
1994: Mei-Ping Kung; Zhi-Ping Zhuang; D Frederick; Hank F Kung
In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
Synapse (New York, N.Y.) 1994;18(4):359-66.
1994: Mei-Ping Kung; S Chumpradit; D Frederick; S Garner; K D Burris; P B Molinoff; Hank F Kung
Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(6):611-7.
1994: S Chumpradit; Mei-Ping Kung; JM Vessotskie; C Foulon; M Mu; Hank F Kung
Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Journal of medicinal chemistry 1994;37(24):4245-50.
1994: Mei-Ping Kung; D J Canney; D Frederick; Z Zhuang; J J Billings; Hank F Kung
Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites.
Synapse (New York, N.Y.) 1994;18(3):225-32.
1994: L C Francesconi; Y Y Yang; Mei-Ping Kung; X X Zhang; J J Billings; Y Z Guo; Hank F Kung
Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand.
Journal of medicinal chemistry 1994;37(20):3282-8.
1994: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.
Journal of medicinal chemistry 1994;37(10):1406-7.
1994: K D Burris; T M Filtz; S Chumpradit; Mei-Ping Kung; C Foulon; Julie Hensler; Hank F Kung; P B Molinoff
Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
The Journal of pharmacology and experimental therapeutics 1994;268(2):935-42.
1994: S E Garner; Mei-Ping Kung; C Foulon; S Chumpradit; Hank F Kung
[125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Life sciences 1994;54(9):593-603.
1994: Hank F Kung; Mei-Ping Kung; W Clarke; S Maayani; Zhi-Ping Zhuang
A potential 5-HT1A receptor antagonist: p-MPPI.
Life sciences 1994;55(19):1459-62.
1993: S Chumpradit; Mei-Ping Kung; Hank F Kung
Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(26):4308-12.
1993: J J Billings; Y Z Guo; Mei-Ping Kung; Hank F Kung
Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
European journal of nuclear medicine 1993;20(12):1146-53.
1993: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
Journal of medicinal chemistry 1993;36(21):3161-5.
1993: C Foulon; Mei-Ping Kung; Hank F Kung
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(10):1499-500.
1993: Y Z Guo; Mei-Ping Kung; H Cheng; N Pfeiffer; D Mozley; Hank F Kung
A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note.
European journal of nuclear medicine 1993;20(5):373-8.
1993: Mei-Ping Kung; Hank F Kung; S Chumpradit; C Foulon
In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
European journal of pharmacology 1993;235(1):165-6.
1993: S Chumpradit; Mei-Ping Kung; J Billings; Robert H Mach; Hank F Kung
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Journal of medicinal chemistry 1993;36(2):221-8.
1992: S Chumpradit; Mei-Ping Kung; C Panyachotipun; V Prapansiri; C Foulon; B P Brooks; S A Szabo; Shanaz Tejani-Butt; Alan Frazer; Hank F Kung
Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites.
Journal of medicinal chemistry 1992;35(23):4492-7.
1992: Y Ohmomo; L Francesconi; Mei-Ping Kung; Hank F Kung
New conformationally restricted 99mTc N2S2 complexes as myocardial perfusion imaging agents.
Journal of medicinal chemistry 1992;35(1):157-62.
1992: Mei-Ping Kung; S Chumpradit; J Billings; H Kung
4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
Life sciences 1992;51(2):95-106.
1992: J J Billings; Mei-Ping Kung; S Chumpradit; D Mozley; Abass Alavi; Hank F Kung
Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Journal of neurochemistry 1992;58(1):227-36.
1991: S Chumpradit; Mei-Ping Kung; J J Billings; Hank F Kung
Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
Journal of medicinal chemistry 1991;34(3):877-83.
1991: Mei-Ping Kung; B L Liu; Y Y Yang; J J Billings; Hank F Kung
A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(2):339-42.
1991: C S John; Mei-Ping Kung; J Billings; Hank F Kung
Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(5):551-6.
1990: Hank F Kung; B L Liu; D Mankoff; Mei-Ping Kung; J J Billings; L Francesconi; Abass Alavi
A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(10):1635-40.
1990: Mei-Ping Kung; Hank F Kung; J Billings; Y Yang; R A Murphy; Abass Alavi
The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):648-54.
1990: Hank F Kung; Abass Alavi; W Chang; Mei-Ping Kung; J W Keyes; M G Velchik; J Billings; S Pan; R Noto
In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):573-9.
1990: R A Murphy; Hank F Kung; Mei-Ping Kung; J Billings
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Journal of medicinal chemistry 1990;33(1):171-8.
1989: B S Schonwetter; R R Luedtke; Mei-Ping Kung; J Billings; Hank F Kung; P B Molinoff
Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
The Journal of pharmacology and experimental therapeutics 1989;250(1):110-6.
1989: S Chumpradit; Hank F Kung; J Billings; Mei-Ping Kung; S Pan
(+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.
Journal of medicinal chemistry 1989;32(7):1431-5.
1989: Hank F Kung; S Pan; Mei-Ping Kung; J Billings; R Kasliwal; J Reilley; Abass Alavi
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(1):88-92.
1989: J Billings; Mei-Ping Kung; S Chumpradit; S Pan; Hank F Kung
[125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.
Life sciences 1989;45(8):711-8.
1988: Hank F Kung; R Kasliwal; S G Pan; Mei-Ping Kung; Robert H Mach; Y Z Guo
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Journal of medicinal chemistry 1988;31(5):1039-43.